Caspofungin treatment of Aspergillus fumigatus results in ChsG-dependent upregulation of chitin synthesis and the formation of chitin-rich microcolonies

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 10, 2015, Pages 5932-5941

  Walker, Louise A ^a,b   Lee, Keunsook K ^a   Munro, Carol A ^a   Gow, Neil A R ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF MAINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; CHITIN; ECHINOCANDIN; NIKKOMYCIN Z; AMINOGLYCOSIDE; ANTIFUNGAL AGENT; BENZENESULFONIC ACID DERIVATIVE; C.I. FLUORESCENT BRIGHTENING AGENT 28; CALCINEURIN; CALCIUM CHLORIDE; CHITIN SYNTHASE; ENZYME INHIBITOR; FLUORESCENT DYE; FUNGAL PROTEIN; LIPOPEPTIDE; NIKKOMYCIN; PROTEIN KINASE C;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS FUMIGATUS; CELL WALL; COLONY FORMATION; CONTROLLED STUDY; DRUG POTENTIATION; FUNGUS HYPHAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SYNTHESIS; UPREGULATION; AGONISTS; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CALCIUM SIGNALING; CHEMISTRY; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; MUTATION;

AMINOGLYCOSIDES; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; BENZENESULFONATES; CALCINEURIN; CALCIUM CHLORIDE; CALCIUM SIGNALING; CELL WALL; CHITIN; CHITIN SYNTHASE; DRUG SYNERGISM; ECHINOCANDINS; ENZYME INHIBITORS; FLUORESCENT DYES; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HYPHAE; LIPOPEPTIDES; MICROBIAL SENSITIVITY TESTS; MUTATION; PROTEIN KINASE C;

EID: 84942291912     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00862-15     Document Type: Article

References (64)

1. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. 2012. Hidden killers: human fungal infections. Sci Transl Med 4:165rv13. http://dx.doi.org/10.1126/scitranslmed.3004404.
2. Mellado E, Aufauvre-Brown A, Specht CA, Robbins PW, Holden DW. 1995. A multigene family related to chitin synthase genes of yeast in the opportunistic pathogen Aspergillus fumigatus. Mol Gen Genet 246:353-359. http://dx.doi.org/10.1007/BF00288608.
3. Latge JP. 2007. The cell wall: a carbohydrate armour for the fungal cell. Mol Microbiol 66:279-290. http://dx.doi.org/10.1111/j.1365-2958.2007.05872.x.
4. Latge JP. 2001. The pathobiology of Aspergillus fumigatus. Trends Microbiol 9:382-389. http://dx.doi.org/10.1016/S0966-842X(01)02104-7.
5. Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, Rodriguez-Tudela JL. 2008. Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification. Antimicrob Agents Chemother 52:1244-1251. http://dx.doi.org/10.1128/AAC.00942-07.
6. van der Linden JW, Snelders E, Kampinga GA, Rijnders BJ, Mattsson E, Debets-Ossenkopp YJ, Kuijper EJ, Van Tiel FH, Melchers WJ, Verweij PE. 2011. Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009. Emerg Infect Dis 17:1846-1854. http://dx.doi.org/10.3201/eid1710.110226.
7. Lionakis MS, Lewis RE, Torres HA, Albert ND, Raad II, Kontoyiannis DP. 2005. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn Microbiol Infect Dis 52:15-20. http://dx.doi.org/10.1016/j.diagmicrobio.2005.01.001.
8. Perkhofer S, Lass-Florl C, Hell M, Russ G, Krause R, Honigl M, Geltner C, Auberger J, Gastl G, Mitterbauer M, Willinger B, Knobl P, Resch G, Waldner R, Makrai A, Hartmann G, Girschikofsky M, Greil R. 2010. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int J Antimicrob Agents 36:531-536. http://dx.doi.org/10.1016/j.ijantimicag.2010.08.010.
9. Verweij PE, Snelders E, Kema GH, Mellado E, Melchers WJ. 2009. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis 9:789-795. http://dx.doi.org/10.1016/S1473-3099(09)70265-8.
10. Howard SJ, Harrison E, Bowyer P, Varga J, Denning DW. 2011. Cryptic species and azole resistance in the Aspergillus niger complex. Antimicrob Agents Chemother 55:4802-4809. http://dx.doi.org/10.1128/AAC.00304-11.
11. Epaulard O, Villier C, Ravaud P, Chosidow O, Blanche S, Mamzer-Bruneel MF, Thiebaut A, Leccia MT, Lortholary O. 2013. A multistep voriconazole-related phototoxic pathway may lead to skin carcinoma: results from a French nationwide study. Clin Infect Dis 57:e182-e188. http://dx.doi.org/10.1093/cid/cit600.
12. Bowman JC, Hicks PS, Kurtz MB, Rosen H, Schmatz DM, Liberator PA, Douglas CM. 2002. The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro. Antimicrob Agents Chemother 46:3001-3012. http://dx.doi.org/10.1128/AAC.46.9.3001-3012.2002.
13. Odds FC, Brown AJ, Gow NA. 2003. Antifungal agents: mechanisms of action. Trends Microbiol 11:272-279. http://dx.doi.org/10.1016/S0966-842X(03)00117-3.
14. Kurtz MB, Heath IB, Marrinan J, Dreikorn S, Onishi J, Douglas C. 1994. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase. Antimicrob Agents Chemother 38:1480-1489. http://dx.doi.org/10.1128/AAC.38.7.1480.
15. Arikan S, Lozano-Chiu M, Paetznick V, Rex JH. 2001. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother 45:327-330. http://dx.doi.org/10.1128/AAC.45.1.327-330.2001.
16. Espinel-Ingroff A. 2003. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev Iberoam Micol 20:121-136.
17. Imhof A, Balajee SA, Marr KA. 2003. New methods to assess susceptibilities of Aspergillus isolates to caspofungin. J Clin Microbiol 41:5683-5688. http://dx.doi.org/10.1128/JCM.41.12.5683-5688.2003.
18. Beauvais A, Bruneau JM, Mol PC, Buitrago MJ, Legrand R, Latge JP. 2001. Glucan synthase complex of Aspergillus fumigatus. J Bacteriol 183:2273-2279. http://dx.doi.org/10.1128/JB.183.7.2273-2279.2001.
19. Walker LA, Munro CA, de Bruijn I, Lenardon MD, McKinnon A, Gow NA. 2008. Stimulation of chitin synthesis rescues Candida albicans from echinocandins. PLoS Pathog 4:e1000040. http://dx.doi.org/10.1371/journal.ppat.1000040.
20. Cota JM, Grabinski JL, Talbert RL, Burgess DS, Rogers PD, Edlind TD, Wiederhold NP. 2008. Increases in SLT2 expression and chitin content are associated with incomplete killing of Candida glabrata by caspofungin. Antimicrob Agents Chemother 52:1144-1146. http://dx.doi.org/10.1128/AAC.01542-07.
21. Fortwendel JR, Juvvadi PR, Pinchai N, Perfect BZ, Alspaugh JA, Perfect JR, Steinbach WJ. 2009. Differential effects of inhibiting chitin and 1,3-β-D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus. Antimicrob Agents Chemother 53:476-482. http://dx.doi.org/10.1128/AAC.01154-08.
22. Walker LA, Gow NA, Munro CA. 2013. Elevated chitin content reduces the susceptibility of Candida species to caspofungin. Antimicrob Agents Chemother 57:146-54. http://dx.doi.org/10.1128/AAC.01486-12.
23. 2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans. Mol Microbiol 63:1399-1413. http://dx.doi.org/10.1111/j.1365-2958.2007.05588.x.
24. Mora-Montes HM, Netea MG, Ferwerda G, Lenardon MD, Brown GD, Mistry AR, Kullberg BJ, O'Callaghan CA, Sheth CC, Odds FC, Brown AJ, Munro CA, Gow NA. 2011. Recognition and blocking of innate immunity cells by Candida albicans chitin. Infect Immun 79:1961-1970. http://dx.doi.org/10.1128/IAI.01282-10.
25. Lee KK, Maccallum DM, Jacobsen MD, Walker LA, Odds FC, Gow NA, Munro CA. 2012. Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo. Antimicrob Agents Chemother 56:208-217. http://dx.doi.org/10.1128/AAC.00683-11.
26. Mellado E, Aufauvre-Brown A, Gow NA, Holden DW. 1996. The Aspergillus fumigatus chsC and chsG genes encode class III chitin synthases with different functions. Mol Microbiol 20:667-679. http://dx.doi.org/10.1046/j.1365-2958.1996.5571084.x.
27. Mellado E, Specht CA, Robbins PW, Holden DW. 1996. Cloning and characterization of chsD, a chitin synthase-like gene of Aspergillus fumigatus. FEMS Microbiol Lett 143:69-76. http://dx.doi.org/10.1111/j.1574-6968.1996.tb08463.x.
28. Jimenez-Ortigosa C, Aimanianda V, Muszkieta L, Mouyna I, Alsteens D, Pire S, Beau R, Krappmann S, Beauvais A, Dufrene YF, Roncero C, Latge JP. 2012. Chitin synthases with a myosin motor-like domain control the resistance of Aspergillus fumigatus to echinocandins. Antimicrob Agents Chemother 56:6121-6131. http://dx.doi.org/10.1128/AAC.00752-12.
29. Muszkieta L, Aimanianda V, Mellado E, Gribaldo S, Alcazar-Fuoli L, Szewczyk E, Prevost MC, Latge JP. 2014. Deciphering the role of the chitin synthase families 1 and 2 in the in vivo and in vitro growth of Aspergillus fumigatus by multiple gene targeting deletion. Cell Microbiol 16:1784-1805. http://dx.doi.org/10.1111/cmi.12326.
30. Borgia PT, Iartchouk N, Riggle PJ, Winter KR, Koltin Y, Bulawa CE. 1996. The chsB gene of Aspergillus nidulans is necessary for normal hyphal growth and development. Fungal Genet Biol 20:193-203. http://dx.doi.org/10.1006/fgbi.1996.0035.
31. Mellado E, Dubreucq G, Mol P, Sarfati J, Paris S, Diaquin M, Holden DW, Rodriguez-Tudela JL, Latge JP. 2003. Cell wall biogenesis in a double chitin synthase mutant (chsG-/chsE-) of Aspergillus fumigatus. Fungal Genet Biol 38:98-109. http://dx.doi.org/10.1016/S1087-1845(02)00516-9.
32. Aufauvre-Brown A, Mellado E, Gow NAR, Holden DW. 1997. Aspergillus fumigatus chsE: a gene related to CHS3 of Saccharomyces cerevisiae and important for hyphal growth and conidiophore development but not pathogenicity. Fungal Genet Biol 21:141-152. http://dx.doi.org/10.1006/fgbi.1997.0959.
33. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard - 2nd ed. CLSI document M38-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
34. Hilenski LL, Naider F, Becker JM. 1986. Polyoxin D inhibits colloidal gold-wheat germ agglutinin labelling of chitin in dimorphic forms of Candida albicans. J Gen Microbiol 132:1441-1451.
35. Munro CA, Winter K, Buchan A, Henry K, Becker JM, Brown AJ, Bulawa CE, Gow NA. 2001. Chs1 of Candida albicans is an essential chitin synthase required for synthesis of the septum and for cell integrity. Mol Microbiol 39:1414-1426.
36. Tronchin G, Poulain D, Herbaut J, Biguet J. 1981. Localization of chitin in the cell wall of Candida albicans by means of wheat germ agglutinin. Fluorescence and ultrastructural studies. Eur J Cell Biol 26:121-128.
37. Reynolds ES. 1963. The use of lead citrate at high pH as an electronopaque stain in electron microscopy. J Cell Biol 17:208-212. http://dx.doi.org/10.1083/jcb.17.1.208.
38. Fortwendel JR, Juvvadi PR, Perfect BZ, Rogg LE, Perfect JR, Steinbach WJ. 2010. Transcriptional regulation of chitin synthases by calcineurin controls paradoxical growth of Aspergillus fumigatus in response to caspofungin. Antimicrob Agents Chemother 54:1555-1563. http://dx.doi.org/10.1128/AAC.00854-09.
39. Verwer PE, van Duijn ML, Tavakol M, Bakker-Woudenberg IA, van de Sande WW. 2012. Reshuffling of Aspergillus fumigatus cell wall components chitin and beta-glucan under the influence of caspofungin or nikkomycin Z alone or in combination. Antimicrob Agents Chemother 56:1595-1598. http://dx.doi.org/10.1128/AAC.05323-11.
40. Pavie J, Lacroix C, Hermoso DG, Robin M, Ferry C, Bergeron A, Feuilhade M, Dromer F, Gluckman E, Molina JM, Ribaud P. 2005. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis. J Clin Microbiol 43:4902-4904. http://dx.doi.org/10.1128/JCM.43.9.4902-4904.2005.
41. Madureira A, Bergeron A, Lacroix C, Robin M, Rocha V, de Latour RP, Ferry C, Devergie A, Lapalu J, Gluckmana E, Socie G, Ghannoum M, Ribaud P. 2007. Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin. Int J Antimicrob Agents 30:551-554. http://dx.doi.org/10.1016/j.ijantimicag.2007.07.026.
42. Wetzstein GA, Green MR, Greene JN. 2007. Mould breakthrough in immunosuppressed adults receiving anidulafungin: a report of 2 cases. J Infect 55:e131-3. http://dx.doi.org/10.1016/j.jinf.2007.08.003.
43. Antachopoulos C, Meletiadis J, Sein T, Roilides E, Walsh TJ. 2008. Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia. Antimicrob Agents Chemother 52:321-328. http://dx.doi.org/10.1128/AAC.00699-07.
44. Eschertzhuber S, Velik-Salchner C, Hoermann C, Hoefer D, Lass-Florl C. 2008. Caspofungin-resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case report. Transpl Infect Dis 10:190-192. http://dx.doi.org/10.1111/j.1399-3062.2007.00252.x.
45. Lafaurie M, Lapalu J, Raffoux E, Breton B, Lacroix C, Socie G, Porcher R, Ribaud P, Touratier S, Molina JM. 2010. High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia. Clin Microbiol Infect 16:1191-1196. http://dx.doi.org/10.1111/j.1469-0691.2009.03050.x.
46. Pang KA, Godet C, Fekkar A, Scholler J, Nivoix Y, Letscher-Bru V, Massias L, Kauffmann-Lacroix C, Elsendoorn A, Uzunov M, Datry A, Herbrecht R. 2012. Breakthrough invasive mould infections in patients treated with caspofungin. J Infect 64:424-429. http://dx.doi.org/10.1016/j.jinf.2011.12.015.
47. Lamoth F, Juvvadi PR, Gehrke C, Steinbach WJ. 2013. In vitro activity of calcineurin and heat shock protein 90 inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains. Antimicrob Agents Chemother 57:1035-1039. http://dx.doi.org/10.1128/AAC.01857-12.
48. Morris SK, Allen UD, Gupta S, Richardson SE. 2012. Breakthrough filamentous fungal infections in pediatric hematopoetic stem cell transplant and oncology patients receiving caspofungin. Can J Infect Dis Med Microbiol 23:179-182.
49. Gardiner RE, Souteropoulos P, Park S, Perlin DS. 2005. Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin. Med Mycol 43(Suppl):S299-S305.
50. Rocha EM, Garcia-Effron G, Park S, Perlin DS. 2007. A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus. Antimicrob Agents Chemother 51:4174-4176. http://dx.doi.org/10.1128/AAC.00917-07.
51. Arendrup MC, Garcia-Effron G, Buzina W, Mortensen KL, Reiter N, Lundin C, Jensen HE, Lass-Florl C, Perlin DS, Bruun B. 2009. Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing. Antimicrob Agents Chemother 53:1185-1193. http://dx.doi.org/10.1128/AAC.01292-08.
52. Stevens DA, Ichinomiya M, Koshi Y, Horiuchi H. 2006. Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin. Antimicrob Agents Chemother 50:3160-3161. http://dx.doi.org/10.1128/AAC.00563-06.
53. Rogg LE, Fortwendel JR, Juvvadi PR, Lilley A, Steinbach WJ. 2011. The chitin synthase genes chsA and chsC are not required for cell wall stress responses in the human pathogen Aspergillus fumigatus. Biochem Biophys Res Commun 411:549-554. http://dx.doi.org/10.1016/j.bbrc.2011.06.180.
54. Kim KW, Hyun JW. 2007. Nonhost-associated proliferation of intrahyphal hyphae of citrus scab fungus Elsinoe fawcettii: refining the perception of cell-within-a-cell organization. Micron 38:565-571. http://dx.doi.org/10.1016/j.micron.2006.10.007.
55. Kelly J, Rowan R, McCann M, Kavanagh K. 2009. Exposure to caspofungin activates Cap and Hog pathways in Candida albicans. Med Mycol 47:697-706. http://dx.doi.org/10.3109/13693780802552606.
56. Wiederhold NP, Kontoyiannis DP, Prince RA, Lewis RE. 2005. Attenuation of the activity of caspofungin at high concentrations against Candida albicans: possible role of cell wall integrity and calcineurin pathways. Antimicrob Agents Chemother 49:5146-5148. http://dx.doi.org/10.1128/AAC.49.12.5146-5148.2005.
57. Sandovsky-Losica H, Shwartzman R, Lahat Y, Segal E. 2008. Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B. J Antimicrob Chemother 62:635-637. http://dx.doi.org/10.1093/jac/dkn216.
58. Steinbach WJ, Cramer RA, Jr, Perfect BZ, Henn C, Nielsen K, Heitman J, Perfect JR. 2007. Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus. Antimicrob Agents Chemother 51:2979-2981. http://dx.doi.org/10.1128/AAC.01394-06.
59. Ganesan LT, Manavathu EK, Cutright JL, Alangaden GJ, Chandrasekar PH. 2004. In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus. Clin Microbiol Infect 10:961-966. http://dx.doi.org/10.1111/j.1469-0691.2004.00996.x.
60. Stevens DA. 2000. Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (nikkomycin Z) for inhibition and killing of fungal pathogens. Antimicrob Agents Chemother 44:2547-2548. http://dx.doi.org/10.1128/AAC.44.9.2547-2548.2000.
61. Fernandes C, Anjos J, Walker LA, Silva BM, Cortes L, Mota M, Munro CA, Gow NA, Goncalves T. 2014. Modulation of Alternaria infectoria cell wall chitin and glucan synthesis by cell wall synthase inhibitors. Antimicrob Agents Chemother 58:2894-2904. http://dx.doi.org/10.1128/AAC.02647-13.
62. Chiou CC, Mavrogiorgos N, Tillem E, Hector R, Walsh TJ. 2001. Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus. Antimicrob Agents Chemother 45:3310-3321. http://dx.doi.org/10.1128/AAC.45.12.3310-3321.2001.
63. Clemons KV, Stevens DA. 2006. Animal models testing monotherapy versus combination antifungal therapy: lessons learned and future directions. Curr Opin Infect Dis 19:360-364. http://dx.doi.org/10.1097/01.qco.0000235163.70678.59.
64. Luque JC, Clemons KV, Stevens DA. 2003. Efficacy of micafungin alone or in combination against systemic murine aspergillosis. Antimicrob Agents Chemother 47:1452-1455. http://dx.doi.org/10.1128/AAC.47.4.1452-1455.2003.